Bright Peak Therapeutics is a startup based in Switzerland, most recent round Series-c-plus, 2 tracked investors.
Bright Peak Therapeutics is a company founded in 2018 headquartered in Switzerland. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Bright Peak Therapeutics is a biotechnology company developing a new generation of cytokine immunotherapies. They focus on creating treatments for cancer and autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.